TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/12 15:05 | 12/11/12 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lorimier Bradley G | CA | D | S.d | -1,021 | 51.06 | 0 | -20 | -71 | 8 | D | |||||||||||||||
5/3/12 18:01 | 5/1/12 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lorimier Bradley G | CA | D | S.d | -931 | 46.55 | 0 | -20 | -71 | 8 | D | |||||||||||||||
1/4/11 17:42 | 1/3/11 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lorimier Bradley G | CA | D | S.d | -470 | 56.41 | 0 | -8 | -50 | 8 | D | |||||||||||||||
1/4/11 17:40 | 1/3/11 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lorimier Bradley G | CA | D | S.d | -654 | 56.06 | 0 | -12 | -59 | 8 | D | |||||||||||||||
6/5/09 16:16 | 6/4/09 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lorimier Bradley G | CA | D | S.ad | -800 | 40.00 | 0 | -20 | -71 | 8 | D | |||||||||||||||
2/26/07 18:45 | 2/22/07 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lorimier Bradley G | CA | D | S.d | -391 | 66.20 | 0 | -6 | -59 | 4 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |